Aduro BioTech Secures $6,500,000 New Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=710f2d73-62f0-4ced-8bb9-4801e59dfe09&Preview=1 -
Date
1/31/2013 -
Company Name
Aduro BioTech -
Mailing Address
626 Bancroft Way Berkeley, CA 94710 -
Company Description
Aduro BioTech is a clinical-stage immunotherapy company with a platform technology for therapeutic and prophylactic vaccines for cancer and infectious diseases. The platform of attenuated and targeted vaccines based on Listeria monocytogenes has been in development for nine years. -
Website
http://www.adurobiotech.com -
Transaction Type
Venture Equity -
Transaction Amount
$6,500,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
This financing will help fund further execution and expansion of Aduro’s targeted immunotherapy development efforts. -
M&A Terms
-
Venture Investor
Undisclosed
